Hepatitis B in Africa Collaborative Research Network (HEPSANET)
Virus targets
Hepatitis B
Type
Operational research
Testing and treatment implementation
Setting
Regional
Phase
Active
WHO region
African Region
Country
Ethiopia
Malawi
Senegal
Burkina Faso
Gambia
Zambia
Sudan
Nigeria
South Africa
Ghana
Key interventions
Linkage to care
Program evaluation
Screening and diagnosis
Strategic data analysis
Treatment
Treatment (direct or referral)
Target population
Adults
Infants (less than one year of age)
Pregnant women
Young Adults <21
Performance target
Care cascade: Evidence of current infection
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Summary and objectives
We are a collaborative research network following patients with hepatitis B at centres in Africa, comprising 16 centres from 10 countries. We aim to tackle important research questions to improve care and outcomes for patients living with chronic hepatitis B.
We are conducting longitudinal follow up of patients with hepatitis B by collecting routinely collected data from different centres across the WHO Africa region.
Our first collaborative paper reporting the performance of low cost biomarkers to predict liver fibrosis has been published in Nature Communications: https://www.nature.com/articles/s41467-022-35729-w
